SuperworthOlema Pharmaceuticals market cap OLMA
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $560.9M
- Highest close in our data
- $2.3B
- Dec 2025
Olema Pharmaceuticals is worth $560.9M at the close on Oct 23, 2026, at $6.41 a share.
That is up 2% over the last year and down 47% over five years.
Its highest close in our data was $2.3B in Dec 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $560.9M | $560.9M | $1.9B | −69% |
| 2025 | $1.8B | $222.1M | $2.3B | +411% |
| 2024 | $352.4M | $349.5M | $863.1M | −54% |
| 2023 | $768.4M | $115.3M | $871.4M | +675% |
| 2022 | $99.1M | $87.2M | $294.1M | −74% |
| 2021 | $377.1M | $377.1M | $1.2B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Olema Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| OLMAOlema Pharmaceuticals | $560.9M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| ARVNArvinas | $477.3M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.2B |
| PCRXPacira BioSciences | $1.5B |
| Peer median | $679.7M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Olema Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.